Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest. Zhao Y, Peng H, Liang L, Li Y, et al. Breast Cancer Res Treat 2022 Jan 26. pii: 10.1007/s10549-021-06490.

Read + Share

Amedeo Smart

Independent Medical Education

Zhao Y, Peng H, Liang L, Li Y, et al. Polarity protein Par3 sensitizes breast cancer to paclitaxel by promoting cell cycle arrest. Breast Cancer Res Treat 2022 Jan 26. pii: 10.1007/s10549-021-06490.
PMID: 35079981